Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-02-001044
Filing Date
2002-06-04
Accepted
2002-06-04 15:57:08
Documents
3
Group Members
ORBIMED ADVISORS INC.ORBIMED ADVISORS LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13G sc13ga_060402.txt SC 13G/A 9931
3 JOINT FILING AGREEMENT ex1_1to13ga.txt EX-1.1 1943
4 STATEMENT OF CONTROL PERSON ex2_1to13ga.txt EX-2.1 807
  Complete submission text file 0000947871-02-001044.txt   15150
Mailing Address 350 MAIN STREET SUITE 307 DOYLESTOWN PA 18901
Business Address 350 MAIN STREET SUITE 307 DOYLESTOWN PA 18901 2152404699
DISCOVERY LABORATORIES INC /DE/ (Subject) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48466 | Film No.: 02670064
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 41 MADISON AVENUE 40TH FLOOR NEW YORK NY 10010 2126850800
ORBIMED ADVISERS INC /CT (Filed by) CIK: 0001033248 (see all company filings)